On air · 2 of 3 networks
Just - Evotec Biologics
- evotec.com
- US
- 606 employees
Just - Evotec Biologics’s ads on LinkedIn, Meta and Google, recorded by adsrunning. Browse the latest here for free. Sign up free to see all 35. Watch Just - Evotec Biologics with Starter to get each new one in your feed.
Watchlist with Starter · $49/mo
| Network | Status | Live ads | Nov 2025LinkedIn activity · 52 weeksOct 2026 | Checked | Next step |
|---|---|---|---|---|---|
| Running | 18 | Checked 29 Oct 2026 | See all 35 ads → | ||
| Meta | Not checked | — | |||
| Running | 200+ | Ads on the Google Ads Transparency Center | Checked 28 Oct 2026 | Collect them with the API → |
Just - Evotec Biologics has 18 live LinkedIn ads. We recorded 200+ Google ads on 28 Oct 2026.
Latest ads
- LINKEDIN · IMAGESince 27 Oct 2026
Bispecific antibodies offer powerful dual-targeting but are difficult to manufacture at scale. Discover how continuous bioprocessing improves yield, product quality, and efficiency. Download the white paper.
- LINKEDIN · IMAGESince 27 Oct 2026
Struggling to scale bispecific antibody production without compromising quality? Explore an integrated approach from molecular design to purification that enables scalable, high-quality manufacturing. Download the white paper.
- LINKEDIN · IMAGESince 7 Jul 2026
Bispecific and multispecific antibodies offer significant therapeutic potential but present complex manufacturing challenges. In this white paper, discover how Just – Evotec Biologics applies an integrated approach combining AI-driven molecular design, advanced cell line development, and continuous bioprocessing to improve productivity, quality, and scalability.
- LINKEDIN · IMAGESince 6 Jul 2026
The complexity of bispecific antibodies demands a smarter development strategy. Download this whitepaper to learn how AI/ML design and continuous bioprocessing improve yield and quality.
- LINKEDIN · IMAGESince 12 Mar 2026
What direction is the #bioprocessing industry heading in 2026? What are the trends and strategies shaping the future of #biopharma? Find the answer in the latest BioProcess Int. eBook “The Future of Bioprocessing: BPI Benchmark Report 2026”. We are contributing with a lead article “𝗙𝗿𝗼𝗺 𝗱𝗲𝘀𝗶𝗴𝗻 𝘁𝗼 𝗽𝗿𝗼𝗱𝘂𝗰𝘁𝗶𝗼𝗻: 𝗛𝗼𝘄 𝗝𝘂𝘀𝘁 – 𝗘𝘃𝗼𝘁𝗲𝗰 𝗕𝗶𝗼𝗹𝗼𝗴𝗶𝗰𝘀 𝗶𝘀 𝗼𝗽𝘁𝗶𝗺𝗶𝘇𝗶𝗻𝗴 𝗯𝗶𝗼𝗺𝗮𝗻𝘂𝗳𝗮𝗰𝘁𝘂𝗿𝗶𝗻𝗴”. 🔗 𝗗𝗼𝗻’𝘁 𝗺𝗶𝘀𝘀 𝘁𝗵𝗶𝘀 𝗲𝗕𝗼𝗼𝗸: https://lnkd.in/dqWkX4Az #biologics #biotherapeutics
- LINKEDIN · IMAGESince 9 Mar 2026
Better #biologics manufacturing starts with the right medium. High-performance perfusion media are the engines of modern bioprocessing. Our latest whitepaper takes you inside 𝗝.𝗠𝗲𝗱𝗶𝗮™, our next-generation #CHO perfusion medium designed to maximize productivity while simplifying logistics. Highlights from the study: 🔹Market-Leading Productivity: Achieved volumetric productivity of 3-4 g/L/d, significantly outperforming leading commercial media 🔹Efficient Metabolism: Reduced lactate and ammonia production, ensuring more carbon is funneled into your protein of interest 🔹Robust Scalability: Proven performance from 3 L bench scale to 500 L SUB, maintaining critical quality attributes (CQAs) throughout 🔹Operational & Logistical Freedom: Room temperature stability for both liquid and powder formats reduces cold chain footprint and storage demands, enhancing supply chain flexibility. 🔗 Download the full whitepaper: https://lnkd.in/d9DcS5FR #bioprocessing #biomanufacturing
6 of 35 adsSign up to see every Just - Evotec Biologics ad, filter by format and date, and get alerts on new ones.
See all 35 adsWatch the companies you care about.
Filter every ad by industry, country, format and network, and get alerts when a company you watch starts running new ads.